Keywords
- Hyaluronic Acid
- Stress Urinary Incontinence
- Bladder Neck
- Intrinsic Sphincter Deficiency
- Injectable Agent
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Murless BC. 1938; The injection treatment of stress incontinence. J Obstet Gynecol Br Emp 45:521–524.
Quackels R. 1955; Deux incontinence apr; ages adenonectomie: Queries par injection de paraffine dans la perin; aaee. Acta Urol Belg 23:259–262.
Sachse H. 1963; Treatment of urinary incontinence with sclerosing solutions: Indications, results, complications. Urol Int 15:225–244.
Dmochowski RR, Appell RA. 2000; Injectable agents in the treatment of stress urinary incontinence in women: Where are we now? Urology 56:(Suppl 6A)32–40.
Crystle CD, Charme LS, Copeland WE. 1971; Q-tip test in stress urinary incontinence. Obstet Gynecol 39:313–315.
Appell RA, Ostergard D. 1992; Practical urodynamics. Illustr Med Female Urol Ser 2:4–29.
Kreder KJ, Austin JC. 1996; Treatment of stress urinary incontinence in women with urethral hypermobility and intrinsic sphincter deficiency. J Urol 156:1995–198.
Smith DN, Appell RA, Winters JC,. et al. 1997; Collagen injection therapy for female intrinsic sphincter deficiency. J Urol 152:1275–1278.
Herschorn S, Radomski SB, Steele DJ. 1992; Early experience with intraurethral collagen injection for urinary incontinence. J Urol 148:1797–1800.
Herschorn S, Radomski SB. 1997; Collagen injections for genuine stress urinary incontinence: Patient selection and durability. Int Urogynecol J 8:18–24.
Faerber GJ. 1995; Endoscopic collagen injection therapy for elderly women with type I stress urinary incontinence. J Urol 153:527A.
Winters J, Chiverton A, Scarpero H,. et al. 2000; Collagen injection therapy in elderly women: Long-term results and patient satisfaction. Urology 55:815–818.
Steele AC, Kohli N, Karram MM. 2000; Periurethral collagen injection for stress incontinence with and without urethral hypermobility. Obstet Gynecol 95:322–331.
Bent, AE, Foote, J, Siegel S,. et al. 2001; Collagen implant for treating stress urinary incontinence in women with urethral hypermobility. J Urol 166:(4)1354–1357.
Winters JC. 2004; Urodynamics in the era of tension-free slings. Curr Urol Rep 5:(5)343–347.
O’Connell HE, McGuire EJ. 1995; Transurethral collagen therapy in women. J Urol 154:1463–1465.
Appell RA. 1990; Injectables for urethral incompetence. World J Urol 8:208–211.
Appell RA. 1994.The periurethral injection of autologous blood. Presented at the American Urogynecologic Society annual meeting, Toronto,
Neal ED Jr Lahaye ME, Lowe DC. 1995; Improved needle placement technique in periurethral collagen injection. Urology 45:865–866.
Faerber GJ, Belville WD, Ohl DA,. et al. 1998; Comparison of transurethral versus periurethral collagen injection in women with intrinsic sphincter deficiency. Tech Urol 4:(3)124–127.
Schulz JA, Nager CW, Stanton SL,. et al. 2004; Bulking agents for stress urinary incontinence: Short-term results and complications in a randomized comparison of periurethral and transurethral injection. Int Urogynecol J Pelvic Floor Dysfunct 15:261–265.
Appell RA. 1996: Collagen injections. In: Raz S, ed. Female urology. 2nd ed. WB Saunders, Philadelphia: 399–405.
Defreitas GA, Wilson TS, Zimmern PE,. et al. 2003; Three-dimensional ultrasonography: An objective outcome to assess collagen distribution in women with stress urinary incontinence. Urology 62:232–236.
Poon CI, Zimmern PE, Defreitas GA,. et al. 2005; Three-dimensional ultrasonography to assess long-term durability of periurethral collagen in women with stress urinary incontinence due to intrinsic sphincteric deficiency. Urology 65:60–64.
Cross CA, English SF, Cespedes RD,. et al. 1998; A follow-up on transurethral collagen injection therapy for urinary incontinence. J Urol 159:106–108.
Stothers L, Goldenberg SL, Leone EF. 1998; Complications of periurethral collagen injection for stress urinary incontinence. J Urol 159:(3)806–807.
Bergman A, Koonings PP, Ballard CA. 1990; Negative Q-tip test as a risk factor for failed incontinence surgery in women. J Reprod Med 34:(3)193–197.
Segal JL, Vasallo BJ, Kleeman SD,. et al. 2006; The efficacy of tension-free vaginal tape in the treatment of five subtypes of stress urinary incontinence. Int J Pelvic Floor Dysfunct 17:(2)120–124.
Gonzalez de Garibay AS, Castro-Morrondo JM, Castro-Jimeno JM. 1989; Endoscopic injection of autologous adipose tissue in the treatment of female incontinence. Arch Esp Urol 42:143–146.
Gonzalez de Garibay AS, Castillo-Jimeno JM, Villanueva-Perez PI. 1991; Treatment of urinary stress incontinence using paraurethral injection of autologous fat. Arch Esp Urol 44:595–600.
Santarosa RP, Blaivas JG. 1994; Periurethral injection of autologous fat for the treatment of sphincteric incontinence. J Urol 151:607–611.
Blaivas JG, Herwitz D, Santarosa RP, et al. 1994; Periurethral fat injection for sphincteric incontinence in women. J Urol 151:419A.
Lee PE, Kung RC, Drutz HP. 2000; Periurethral autologous fat injection as treatment for female stress urinary incontinence: A randomized double-blind controlled trial. J Urol 165: 153–158.
Bartynski J, Marion MS, Wang TD. 1990; Histopathologic evaluation of adipose autografts in a rabbit ear model. Otolaryngology 102:314.
Sweat SD, Lightner DJ. 1999; Complications of sterile abscess formation and pulmonary embolism following periurethral bulking agents. J Urol 161:93–96.
Moalli PA, Shand SH, Zyczynski HM,. et al. 2005; Remodeling of vaginal connective tissue in patients with pelvic organ prolpase. Obstet Gynecol 106:(5 Pt 1)953–963.
DeLustro F, Dasch J, Keefe J,. et al. 1990; Immune response to allogeneic and xenogeneic implants of collagen and collagen derivatives. Clin Orthop 260:263–279.
McPherson JM, Sawamura S, Armstrong R. 1986; An examination of the biologic response to injectable glutaraldehyde cross-linked collagen implants. J Biomed Matter Res 20:93–97.
DeLustro F, Keefe J, Fong AT,. et al. 1991; The biochemistry, biology, and immunology of injectable collagens: Contigen Bard collagen implant in treatment of urinary incontinence. Pediatr Surg Int 6:245–251.
Canning DA, Peters CA, Gearhart JR,. et al. 1988; Local tissue reaction to glutaraldehyde cross-linked bovine collagen in the rabbit bladder. J Urol 139:258–259.
Remacle M, Marbaix E. 1988; Collagen implants in the human larynx. Arch Otorhinolaryngol 245:203–209.
Appell RA. 1994; Collagen injection therapy for urinary incontinence. Urol Clin North Am 21:177–182.
Appell RA. 1990; New developments: Injectables for urethral incompetence in women. Int Urogynecol J 1:117–119.
Appell RA, McGuire EJ, DeRidder PA, et al. 1994; Summary of effectiveness and safety in the prospective, open, multicenter investigation of Contigen implant for incontinence due to intrinsic sphincteric deficiency in females. J Urol 151:418A.
Striker P, Haylen B. 1993; Injectable collagen for type 3 female stress incontinence: The first 50 Australian patients. Med J Aust 158:89–91.
Swami SK, Eckford SD, Abrams P. 1994; Collagen injections for female stress incontinence: Conclusions of a multistage analysis and results. J Urol 151:479A.
Appell RA. 1992; Use of collagen injections for treatment of incontinence and reflux. Adv Urol 5:145–165.
Richardson TD, Kennelly MJ, Faerber GJ. 1995; Endoscopic injection of glutaraldehyde cross-linked collagen for the treatment of intrinsic sphincteric deficiency in women. Urology 46:378–381.
Corcos J, Fournier C. 1999; Periurethral collagen injection for the treatment of female stress urinary incontinence: 4-year follow-up results. Urology 54:815–818.
Gorton E, Stanton S, Monga A,. et al. 1999; Periurethral collagen injection: A long-term follow-up study. BJU Int 84:966–971.
Bard CR, Inc. PMAA submission to United States Food and Drug Administration for IDE G850010, 1990.
Ford CN, Martin CW, Warren TF. 1984; Injectable collagen in laryngeal rehabilitation. Laryngoscope 95:513–518.
Stegman S, Chu S, Bensch K,. et al. 1987; A light and electron microscopic evaluation of Zyderm and Zyplast implants in aging human facial skin: A pilot study. Arch Dermatol 123:1644–1649.
DeLustro F, Condell RA, Nguyen MA,. et al. 1986; A comparative study of the biologic and immunologic response to medical devices derived from dermal collagen. J Biomed Mater Res 20:109–120.
McLennan MT, Bent AE. 1998; Suburethral abscess: A complication of periurethral collagen injection therapy. Obstet Gynecol 92:650–652.
Stothers L, Goldenberg SL. 1998; Delayed hypersensitivity and systemic arthralgia following transurethral collagen injection for stress urinary incontinence. J Urol 159:1507–1509.
Berg S. 1973; Polytef augmentation urethroplasty: Correction of surgically incurable urinary incontinence by injection technique. Arch Surg 107:379–381.
Politano VA, Small MP, Harper JM,. et al. 1974; Periurethral Teflon injection for urinary incontinence. J Urol 111:180–183.
Heer H. 1977; Die Behandlung der Harnin-kontinenz mit der Teflon-paste. Urol Int 32:295–302.
Lampante L, Kaesler FP, Sparwasser H. 1979; Endourethrale submukose Tefloninjektion zur Erzielung von Harninkontinenz. Akt Urol 10:265–272.
Lim KB, Ball AJ, Feneley RCL. 1983; Periurethral Teflon injection: A simple treatment for urinary incontinence. Br J Urol 55:208–210.
Schulman CC, Simon J, Wespes E,. et al. 1983; Endoscopic injection of Teflon for female urinary incontinence. Eur Urol 9:246–247.
Deane AM, English P, Hehir M,. et al. 1985; Teflon injection in stress incontinence. Br J Urol 57:78–80.
Appell RA. 1990:Commentary: Periurethral polytetrafluoroethylene (Polytef) injection. In: Whitehead ED, ed. Current operative urology. JB Lippincott, Philadelphia: 63–66.
Cole HM. 1993; Diagnostic and therapeutic technology assessment (DATTA). JAMA 269:2975–2980.
Buckley JF, Lingham K, Meddings RN, et al. 1993; Injectable Teflon paste for female stress incontinence: Long-term follow-up and results. J Urol 149:418A.
Politano VA. 1982; Periurethral polytetrafluoroethylene injection for urinary incontinence. J Urol 127:439–442.
Stone JW, Arnold GE. 1967; Human larynx injected with Teflon paste: Histologic study of innervation and tissue reaction. Arch Otolaryngol 86:550–562.
Politano VA. 1978; Periurethral Teflon injection for urinary incontinence. Urol Clin North Am 5:415–422.
Malizia AA Jr, Reiman JM, Myers RP,. et al. 1984; Migration and granulomatous reaction after periurethral injection of Polytef (Teflon). JAMA 251:3277–3281.
Vandenbossche M, Delhobe O, Dumortier P,. et al. 1994; Endoscopic treatment of reflux: Experimental study and review of Teflon and collagen. Eur Urol 23:386.
Mittleman RE, Marraccini JV. 1983; Pulmonary Teflon granulomas following periurethral Teflon injection for urinary incontinence. Arch Pathol Lab Med 107:611–612.
Claes H, Stroobants D, van Meerbeek J,. et al. 1989; Pulmonary migration following periurethral polytetrafluoroethylene injection for urinary incontinence. J Urol 142:821–822.
Sanfilippo F, Shelburne J, Ingram P. 1980; Analysis of a Polytef granuloma mimicking a cold thyroid nodule 17 months after laryngeal injection. Ultrastruct Pathol 1:471–475.
Oppenheimer BS, Oppenheimer ET, Stout AP,. et al. 1958; The latent period in carcinogenesis by plastics in rats and its relation to the presarcomatous stage. Cancer 11:204–213.
Hakky M, Kolbusz R, Reyes CV. 1989; Chondrosarcoma of the larynx. Ear Nose Throat J 68:60–62.
Lewy RB. 1976; Experience with vocal cord injection. Ann Otol Rhinol Laryngol 85:440–450.
Montgomery WW. 1979; Laryngeal paralysis – Teflon injection. Ann Otol 88:647–657.
Dewan PA. 1992; Is injected polytetrafluoroethylene (Polytef) carcinogenic? Br J Urol 69:29–33.
Dewan PA, Owen AJ, Byard RW. 1995; Long-term histological response to subcutaneously injected Polytef and Bioplastique in a rat model. Br J Urol 76:(2)161–164.
Buckley JF, Scott R, Meddings, et al. 1992; Injectable silicone microparticles: A new treatment for female stress incontinence. J Urol 147:280A.
Buckley JF, Lingham K, Lloyd SN, et al. 1993; Injectable silicone macroparticles for female urinary incontinence. J Urol 149:402A.
Radley SC, Chapple CR, MItsogiannis IC,. et al. 2001; Transurethral implantation of Macroplastique for the treatment of female stress urinary incontinence secondary to intrinsic sphincteric deficiency. Eur Urol 39:383–389.
Tamanini JT, D’Ancona CA, Tadini V,. et al. 2003; Macroplastique implantation system for female stress urinary incontinence. J Urol 169:2229–2233.
Anders K, Khullar V, Cardozo L,. et al. 1999; Gax-collagen or Macroplastique. Does it make a difference? Neururol Urodyn 18:297–298.
Ter Meulen PH, Berghmans LC, van Kerrebroeck PE. 2003; Systematic review: Efficacy of silicone microimplants (Macroplastique) therapy for stress urinary incontinence in adult women. Eur Urol 44:573–582.
Henly DR, Barrett DM, Weiland TL,. et al. 1995; Particulate silicone for use in periurethral injections: Local tissue effects and search for migration. J Urol 153:2039–2043.
Lightner D, Calvosa C, Andersen R,. et al. 2001; A new injectable bulking agent for treatment of stress urinary incontinence: Results of a multicenter, randomized, controlled, double-blind study of Durasphere. Urology 58:12–15.
Pannek J, Brands FH, Senge T. 2001; Particle migration after transurethral injection of carbon coated beads for stress urinary incontinence. J Urol 166:1350–1353.
Madjar S, Covington-Nichols C, Secrest CL. 2003; New periurethral bulking agent for stress urinary incontinence: Modified technique and early results. J Urol 170:2327–2329.
Chrouser KL, Fick F, Goel A,. et al. 2004; Carbon coated zirconium beads in beta-glucan gel and bovine glutaraldehyde cross-linked collagen injections for intrinsic sphincteric deficiency: Continence and satisfaction after extended follow-up. J Urol 171:1152–1155.
United States Food and Drug Administration: Durasphere™ Injectable Bulking Agent. Summary of Safety and Effectiveness Data, 1999. www.fda.gov/cdrh/pdf/p980053.html.
Madjar S, Sharma AK, Waltzer WC,. et al. 2006; Periurethral mass formations following bulking agent injection for the treatment of urinary incontinence. J Urol 175:1408–1410.
Ritts RE. 2002; Particle migration after transurethral injection of carbon coated beads. J Urol 167:1804–1805.
United States Food and Drug Administration. URYX® Urethral bulking agent – P030030 Part II: Summary of safety and effectiveness data, 2004. http://www.fda.gov/cdrh/PDF3/p030030b.
Dmochowski RR, Appell RA. 2003; Advancements in minimally invasive treatments for female stress urinary incontinence: Radiofrequency and bulking agents. Curr Urol Rep 4:350–355.
Dmochowski RR. 2005; Tegress. ™ Urethral implant phase III clinical experience and product uniqueness Rev Urol,7:(Suppl 1)S22–26.
Hurtado EA, McCrery RJ, Appell RA. The safety and efficacy of ethylene vinyl alcohol copolymer as an intra-urethral bulking agent in women with intrinsic urethral deficiency. Int Urogynecol J 2007; 18; 869–73.
Hurtado EA, McCrery RJ, Appell RA. 2008; Complications of ethylene vinyl alcohol copolymer as an intra-urethral bulking agent in men with stress urinary incontinence. Urology 71:662–65.
Mayer R, Lightfoot M, Jung I. 2001; Preliminary evaluation of calcium hydroxylapatite as a transurethral bulking agent for stress urinary incontinence. Urology 57:434–438.
United States Food and Drug Administration. Coaptite® implanted device. www.fda.gov/cdrh/mda/docs/p040047.html, 2005.
Winters JC, Appell RA. 1995; Periurethral injection of collagen in the treatment of intrinsic sphincteric deficiency in the female patient. Urol Clin North Am 22:673–678.
Biomatrix Corporation. Formal report of feasibility study of Hylagel Uro. Corporate white paper. Ridgefield, NJ, June 2000.
Stenberg A, Larsson G, Johnson P,. et al. 1999; DiHA Dextran copolymer, a new biocompatible material for endoscopic treatment of stress incontinent women. Acta Obstet Gynecol Scand 78:436–442.
Stenberg A, Larsson G, Johnson P. 2003; Urethral injection for stress urinary incontinence: Long-term results with dextranomer/hyaluronic acid copolymer. Int Urogynecol J Pelvic Dysfunct 14:335–338.
Van Kerrebroeck P, ter Meulen F, Larsson G,. et al. 2004; Efficacy and safety of a novel system (NASHA/Dx copolymer using the Implacer device) for treatment of stress urinary incontinence. Urology 64:276–281.
Walker RS, Wilson K, Clark AE. 1992; Injectable bioglass as a potential substitute for injectable polytetrafluorethylene. J Urol 148:645–647.
Atala A, Cima LG, Kim W, et al. 1993; Injectable alginate seeded with chondrocytes as a potential treatment for vesicoureteral reflux. J Urol 150:745–747.
Bent AE, Tutrone RT, McLennan, et al. 2001; Treatment of intrinsic sphincter deficiency using autologous ear chondrocytes as a bulking agent. Neurourol Urodyn 20:157–165.
Yokoyama T, Chancellor MB, Watanabe T,. et al. 2000; Primary myoblast injection into urethra and bladder as a potential treatment of stress urinary incontinence and impaired detrusor contractility: Long-term survival without significant cytotoxicity. J Urol 161:307.
Cannon TW, Lee JY, Somogyi G,. et al. 2003; Improved sphincter contractility after allogenic muscle-derived progenitor cell injection into the denervated rat urethra. Urology 62:958–963.
Peyromaure M, Sebe P, Praud C,. et al. 2004; Fate of implanted syngeneic muscle precursor cells in striated urethral sphincter of female rats: Perspectives for the treatment of urinary incontinence. Urology 64:1037–1041.
Pycha A, Klinger CH, Haitel A,. et al. 2000; 3 years experience with implantable microballoons for the treatment of intrinsic sphincter deficiency. J Urol 161:307.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Springer-Verlag London Limited
About this chapter
Cite this chapter
Hurtado, E. ., Appell, R. . (2009). Surgery for Stress Urinary Incontinence: Minimally Invasive Procedures. In: Badlani, G.H., Davila, G.W., Michel, M.C., de la Rosette, J.J.M.C.H. (eds) Continence. Springer, London. https://doi.org/10.1007/978-1-84628-510-3_12
Download citation
DOI: https://doi.org/10.1007/978-1-84628-510-3_12
Publisher Name: Springer, London
Print ISBN: 978-1-84628-510-3
Online ISBN: 978-1-84628-734-3
eBook Packages: MedicineMedicine (R0)